IRCCS Fondazione Stella Maris

At IRCCS Fondazione Stella Maris in Pisa, clinical research in this area focuses on autism spectrum disorders and related challenges in social communication and interaction. The trials are designed to explore whether new treatments can help improve core behavioral symptoms and day-to-day functioning in children and adolescents.

• Psychiatry and Psychology with a focus on behavior and mental disorders
• Studying autism spectrum disorders and core social communication difficulties
• Evaluating a potential therapy aimed at improving symptom control and quality of life

This work reflects a strong interest in better understanding and treating developmental conditions that affect communication, behavior, and social interaction.

Research here also addresses nervous system diseases linked to cerebral palsy, especially dyskinesia due to cerebral palsy with involuntary choreiform movements. The trial landscape is centered on testing whether treatment can reduce abnormal movements and improve daily motor function for both pediatric and adult participants.

• Diseases of the nervous system involving movement control problems
• Studying dyskinesia due to cerebral palsy and associated chorea
• Assessing treatment effectiveness for easing involuntary movements

These studies aim to support more effective symptom management in a complex neurological condition.

Another key area at this hospital and clinic research site is spastic cerebral palsy, a condition that falls within both congenital and hereditary diseases and nervous system disorders. The research is examining the safety and tolerability of a new treatment approach for children, with the goal of improving care for motor impairment and related symptoms.

• Congenital, hereditary, and neonatal diseases alongside nervous system diseases
• Studying spastic cerebral palsy in pediatric participants
• Testing a therapy intended to support safer and more effective symptom control

This line of research highlights the site’s emphasis on pediatric neurological care and treatment development.

Clinical trials at IRCCS Fondazione Stella Maris also include Rett syndrome, a rare neurodevelopmental disorder with significant impact on movement, communication, and overall development. The studies are focused on determining whether a candidate therapy can help manage symptoms and improve outcomes for affected individuals.

• Congenital, hereditary, and neonatal diseases with major neurological involvement
• Studying Rett syndrome and its developmental consequences
• Evaluating a treatment approach for safety and potential benefit

This research adds to the site’s broader work in rare pediatric neurological and behavioral conditions.